01Nov 2023
Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL

Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL

This study investigates Down syndrome (DS) patients with B-cell acute lymphoblastic leukemia (B-ALL) enrolled in Children's Oncology Group trials from 2003 to 2019. DS patients, numbering 743, experienced higher rates of minimal residual disease (MRD) and poorer 5-year event-free survival and overall survival compared to non-DS patients. Multivariable analysis identified risk factors for inferior outcomes in DS patients. They exhibited increased relapse rates and treatment-related mortality, emphasizing the need for less-toxic therapeutic strategies to enhance outcomes.

  • #oncology

Like

Save

Share